CN103908550A - Traditional Chinese medicine for treating coronary heart disease - Google Patents
Traditional Chinese medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN103908550A CN103908550A CN201210594331.3A CN201210594331A CN103908550A CN 103908550 A CN103908550 A CN 103908550A CN 201210594331 A CN201210594331 A CN 201210594331A CN 103908550 A CN103908550 A CN 103908550A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A traditional Chinese medicine for treating coronary heart disease is composed of the following compositions by weight: 200-250 parts of fried radix astragali, 90-130 parts of carthamus tinctorius, 120-150 parts of cornus officinalis, 120-140 parts of poria cocos, 150-200 parts of radix astragali, 150-200 parts of curculigo orchioides, 100-120 parts of eucommia ulmoides, 120-150 parts of trichosanthes kirilowii, 100-120 parts of placenta hominis, 100-150 parts of Chinese yam, 30-50 parts of salvia miltiorrhiza, 20-30 parts of Chinese magnoliavine, 10-15 parts of red date, 120-130 parts of Chinese angelica, 30-40 parts of epimedium brevicornu, 150-180 parts of lycium barbarum, 50-70 parts of artemisia argyi, 30-40 parts of albizia bark, 100-130 parts of phellodendron, 40-50 parts of radix paeoniae rubra and 5-15 parts of cordyceps sinensis. The traditional Chinese medicine is capable of tonifying qi and nourishing yin, strengthening heart and activating pulse, and tranquilizing the mind, is capable of improving myocardial metabolism and enhancing heart functions, and has effects of promoting blood circulation and regulating blood pressure. The traditional Chinese medicine has the efficacy of warming yang and promoting diuresis, activating blood and resolving stasis, promoting blood circulation, and facilitating diuresis and dispersing swelling. Additionally, the traditional Chinese medicine is capable of increasing coronary blood flow, improving myocardial ischemia and anoxia and further alleviating angina pectoris.
Description
Technical field
The present invention relates to a kind of Chinese medicine that is used for the treatment of coronary heart disease, specifically, relate to a kind of Chinese medicine for the mid-aged population of suffering from coronary heart disease is treated.
Background technology
" coronary heart disease " is the abbreviation of coronary heart disease, heart is the vitals of human body, its effect is like being a never out-of-work pump, shrink the blood flow that carries oxygen and nutrient substance is transported to whole body through aorta along with heart is each, to supply with each histiocyte metabolism needs, separate two tremulous pulsies at aortal root, be responsible for the blood circulation of heart itself, be called coronary artery, because lipid metabolism is undesired, lipid calmness in blood is on the endarterium of otherwise smooth, pile up and form white speckle at the lipid material of some similar medicated porridge samples of endarterium, be called atherosclerotic lesion.Arteriosclerosis, according to the difference of its reason, consequence and pathomorphism, can be divided into 3 types substantially: 1. tiny merit arteries and veins is hard.Thicken hardening, the main monckeberg's arteriosclerosis of sending out hypertensive patient.Mostly occur at the medium sized tremulous pulse of extremity, a glue does not cause luminal stenosis, does not produce symptom.2. atherosclerosis.Often occur in large-scale tremulous pulse, as the blood vessel of the significant points such as aorta, coronary artery, cerebral arteries.Atherosclerosis is one and lipidosis, particularly falls and hinders the disease that has substantial connection with smooth sterin metabolism.Pathological changes is early stage, and the cholesterol in blood and other lipids and compound saccharide precipitate in endarterium, then cause inner membrance proliferation of fibrous tissue, and inner membrance swells gradually, thickens, and forms the lark speckle that naked eyes can be seen; Later speckle constantly expands, and core softens, collapses, visible yellow color " medicated porridge sample " material because of undernutrition; Also there is lipid precipitation to get off with the middle level of artery again, and the elastic fiber in middle level and sliding muscle fiber fracture, proliferation of fibrous tissue under tunica intima, be there is gradually, also have marl to get off, result, ductus arteriosus wall just becomes fragile, hardening, tube chamber narrows, and this pathological changes is called atherosclerosis.In the time that doctor trained in Western medicine is carried out coronary heart disease treatment, often, only by Drug therapy or inadequate, need to carry out interventional therapy by operation.And for middle-aged and elderly people, carry out operative treatment and just mean larger operation risk and long postoperative turnaround time, therefore often a lot of patients ' psychological burdens are large, and therefore hang back.
Summary of the invention
The object of the invention is to for the existing toxic and side effects of existing employing doctor trained in Western medicine method treatment coronary heart disease greatly, easily cause patient suffering's deficiency, a kind of novel therapeutic drug of coronary heart disease of making according to theory of Chinese medical science is provided.
Technical scheme of the present invention is: a kind of Chinese medicine for the treatment of coronary heart disease, this medicine is that following composition forms by weight: Radix Astragali Preparata 200-250 part, Flos Carthami 90-130 part, Fructus Corni 120-150 part, Poria 120-140 part, Radix Astragali 150-200 part, Rhizoma Curculiginis 150-200 part, Cortex Eucommiae 100-120 part, Fructus Trichosanthis 120-150 part, Placenta Hominis 100-120 part, Rhizoma Dioscoreae 100-150 part, Radix Salviae Miltiorrhizae 30-50 part, Fructus Schisandrae Chinensis 20-30 part, Fructus Jujubae 10-15 part, Radix Angelicae Sinensis 120-130 part, Herba Epimedii 30-40 part, Fructus Lycii 150-180 part, moxibustion grass 50-70 part, Cortex Albiziae 30-40 part, Cortex Phellodendri 100-130 part, Radix Paeoniae Rubra 40-50 part, Cordyceps 5-15 part.
The preparation method of the Chinese medicine of above-mentioned treatment coronary heart disease, when fried, be first mixed in proportion medicine pulverize, and adds subsequently the water of five times, fried three times of slow fire, and decoction reduces to 1/3 of original water yield after concentrated.
Beneficial effect of the present invention is: adopt this prescription, can supplementing QI and nourishing YIN, the raw arteries and veins of heart tonifying, mind tranquilizing and the heart calming, and can improve myocardial metabolism, strengthen cardiac function, there is blood circulation promoting and regulate the effect of blood pressure.Warming YANG to promote diuresis, blood circulation promoting and blood stasis dispelling, have heart tonifying, the merit of blood circulation promoting and inducing diuresis to remove edema simultaneously.Can increase in addition coronary flow, improve myocardial ischemia, anoxia and angina pectoris is eased.Especially in this Chinese medicine for middle-older patient, adopt the medicine of property of medicine gentleness, reduce body burden, reduce the consumption of the expensive Chinese medicine such as Radix Ginseng, Cordyceps simultaneously, replace common low price medicine, reduce medication person's financial burden.
The specific embodiment
The first specific embodiment of the present invention, a kind of Chinese medicine for the treatment of coronary heart disease, this medicine is that following composition forms by weight: 200 parts of Radix Astragali Preparatas, 90 parts, Flos Carthami, 120 parts of Fructus Corni, 120 parts, Poria, 150 parts of the Radixs Astragali, 150 parts of Rhizoma Curculiginises, 100 parts of the Cortexs Eucommiae, 120 parts of Fructus Trichosanthis, 100 parts of Placenta Hominiss, 100 parts of Rhizoma Dioscoreaes, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of Fructus Schisandrae Chinensis, 10 parts of Fructus Jujubaes, 120 parts of Radix Angelicae Sinensis, 30 parts of Herba Epimedii, 150 parts of Fructus Lyciis, 50 parts of moxibustion grass, 30 parts of Cortex Albiziaes, 100 parts of Cortex Phellodendris, 40 parts of Radix Paeoniae Rubra, 5 parts of Cordyceps.
The second specific embodiment of the present invention, a kind of Chinese medicine for the treatment of coronary heart disease, this medicine is that following composition forms by weight: 220 parts of Radix Astragali Preparatas, 100 parts, Flos Carthami, 140 parts of Fructus Corni, 130 parts, Poria, 170 parts of the Radixs Astragali, 170 parts of Rhizoma Curculiginises, 110 parts of the Cortexs Eucommiae, 130 parts of Fructus Trichosanthis, 110 parts of Placenta Hominiss, 130 parts of Rhizoma Dioscoreaes, 40 parts of Radix Salviae Miltiorrhizaes, 25 parts of Fructus Schisandrae Chinensis, 12 parts of Fructus Jujubaes, 125 parts of Radix Angelicae Sinensis, 35 parts of Herba Epimedii, 170 parts of Fructus Lyciis, 60 parts of moxibustion grass, 35 parts of Cortex Albiziaes, 120 parts of Cortex Phellodendris, 45 parts of Radix Paeoniae Rubra, 10 parts of Cordyceps.
The 3rd specific embodiment of the present invention, a kind of Chinese medicine for the treatment of coronary heart disease, this medicine is that following composition forms by weight: 250 parts of Radix Astragali Preparatas, 130 parts, Flos Carthami, 150 parts of Fructus Corni, 140 parts, Poria, 200 parts of the Radixs Astragali, 200 parts of Rhizoma Curculiginises, 120 parts of the Cortexs Eucommiae, 150 parts of Fructus Trichosanthis, 120 parts of Placenta Hominiss, 150 parts of Rhizoma Dioscoreaes, 50 parts of Radix Salviae Miltiorrhizaes, 30 parts of Fructus Schisandrae Chinensis, 15 parts of Fructus Jujubaes, 130 parts of Radix Angelicae Sinensis, 40 parts of Herba Epimedii, 180 parts of Fructus Lyciis, 70 parts of moxibustion grass, 40 parts of Cortex Albiziaes, 130 parts of Cortex Phellodendris, 50 parts of Radix Paeoniae Rubra, 15 parts of Cordyceps.
When fried, first medicine be mixed in proportion and pulverized, add subsequently the water of five times, fried three times of slow fire, decoction reduces to 1/3 of original water yield after concentrated.While taking this medicine, 15 grams, available Colla Corii Asini, 50 grams of receipts cream of crystal sugar.Take every day 3 times.Take continuously 15 days.After the first quarter moon of interval, then take continuously 15 days, continue to take half a year.
Clinical data:
Each 34 examples of experimental group and contrast groups, experimental group age 33-67 year, 1 age of matched group 35-71 year, 2 age of matched group 42-69 year.Male's 18 examples in experimental group, women's 16 examples, in two matched groups, are male's 20 examples, women's 14 examples, three groups of situations, without significant difference, have comparability.Experimental group adopts the medicine of the specific embodiment of the invention 2, and matched group 1 is taken Nifedipine Tablets, and matched group 2 is taken isosorbide mononitrate sheet.Final result is as shown in the table.
From experimental data, experimental group obvious effective rate 76%, total effective rate 85%, higher than two matched groups.
Claims (2)
1. treat the Chinese medicine of coronary heart disease for one kind, it is characterized in that, this medicine is that following composition forms by weight: Radix Astragali Preparata 200-250 part, Flos Carthami 90-130 part, Herba Cistanches 120-150 part, Poria 120-140 part, Radix Astragali 150-200 part, Rhizoma Curculiginis 150-200 part, Cortex Eucommiae 100-120 part, Fructus Trichosanthis 120-150 part, Placenta Hominis 100-120 part, Rhizoma Dioscoreae 100-150 part, Radix Salviae Miltiorrhizae 30-50 part, Fructus Schisandrae Chinensis 20-30 part, Fructus Jujubae 10-15 divides, Radix Angelicae Sinensis 120-130 part, Herba Epimedii 30-40 part, Fructus Lycii 150-180 part, moxibustion grass 50-70 part, Cortex Albiziae 30-40 part, Cortex Phellodendri 100-130 part, Radix Paeoniae Rubra 40-50 part, Cordyceps 5-15 part.
2. the preparation method of the Chinese medicine for the treatment of coronary heart disease as claimed in claim 1, its feature from: when fried, first medicine be mixed in proportion and pulverized, add subsequently the water of five times, fried three times of slow fire, decoction reduces to 1/3 of original water yield through after concentrated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210594331.3A CN103908550A (en) | 2012-12-31 | 2012-12-31 | Traditional Chinese medicine for treating coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210594331.3A CN103908550A (en) | 2012-12-31 | 2012-12-31 | Traditional Chinese medicine for treating coronary heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103908550A true CN103908550A (en) | 2014-07-09 |
Family
ID=51034754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210594331.3A Pending CN103908550A (en) | 2012-12-31 | 2012-12-31 | Traditional Chinese medicine for treating coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103908550A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1383846A (en) * | 2001-04-29 | 2002-12-11 | 王运景 | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
CN1686502A (en) * | 2005-04-18 | 2005-10-26 | 潘文祥 | Medicine for fortifying human body immune function |
-
2012
- 2012-12-31 CN CN201210594331.3A patent/CN103908550A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1383846A (en) * | 2001-04-29 | 2002-12-11 | 王运景 | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
CN1686502A (en) * | 2005-04-18 | 2005-10-26 | 潘文祥 | Medicine for fortifying human body immune function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102133378B (en) | Medicament for treating breast cancer | |
CN102293947A (en) | Traditional Chinese medicine for treating hypertension | |
CN104127699A (en) | Vitality-tonifying health-preserving preparation and preparation method thereof | |
CN104940740A (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof | |
CN103446503A (en) | Traditional Chinese medicine composition for treating type II diabetes mellitus | |
CN101757376A (en) | Traditional Chinese medicine for treating pityriasis rosea | |
CN101411830A (en) | Prescription for treating diseases of liver, gallbladder, spleen and stomach as well as formulation method thereof | |
CN101664504B (en) | Medicament for treating diabetes and preparation method thereof | |
CN1342477A (en) | Quick-acting hypertension capsule | |
CN103182008A (en) | Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure | |
CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
CN102579633B (en) | Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof | |
CN102451250A (en) | Chinese medicine footbath prescription for treating color spots | |
CN103908550A (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN106074912B (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases | |
CN104474015A (en) | Medicine for lowering blood pressure and blood fat and preparation method of medicine | |
CN103055072A (en) | Traditional Chinese medicine composition for treating stranguria | |
CN102716293A (en) | Capsule for treating hypertension, hyperlipemia, arteriosclerosis and coronary heart disease | |
CN102397391A (en) | Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof | |
CN102423354A (en) | Traditional Chinese medicine for treating hypertension | |
CN106581425A (en) | Pharmaceutical composition for treating | |
CN101081259B (en) | Chinese medicinal materials decoction for treating top-left fenghuo tooth pain | |
CN102151326B (en) | Chinese medicine composition for curing hypertension and hyperlipaemia | |
CN102166303B (en) | Chinese medicinal composition for treating chronic atrophic gastritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140709 |
|
RJ01 | Rejection of invention patent application after publication |